1. Home
  2. CBRS vs GH Comparison

CBRS vs GH Comparison

Compare CBRS & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cerebras Systems Inc. Class A Common Stock

CBRS

Cerebras Systems Inc. Class A Common Stock

N/A

Current Price

$86.94

Market Cap

24.0B

Sector

Technology

ML Signal

N/A

Logo Guardant Health Inc.

GH

Guardant Health Inc.

N/A

Current Price

$145.67

Market Cap

22.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CBRS
GH
Founded
2016
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.0B
22.9B
IPO Year
2024
2018

Fundamental Metrics

Financial Performance
Metric
CBRS
GH
Price
$86.94
$145.67
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
26
Target Price
★ $210.18
$200.76
AVG Volume (30 Days)
★ 9.9M
2.1M
Earning Date
11-12-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 6.74
EPS
N/A
★ N/A
Revenue
N/A
★ $982,021,000.00
Revenue This Year
$82.40
$39.12
Revenue Next Year
$218.73
$34.27
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 32.88
52 Week Low
$77.84
$74.55
52 Week High
$265.63
$191.05

Technical Indicators

Market Signals
Indicator
CBRS
GH
Relative Strength Index (RSI) 36.24 37.10
Support Level $77.84 $138.64
Resistance Level $221.60 $177.55
Average True Range (ATR) 9.85 10.03
MACD 2.51 -1.96
Stochastic Oscillator 24.06 22.67

Price Performance

Historical Comparison
CBRS
GH

About CBRS Cerebras Systems Inc. Class A Common Stock

Cerebras Systems Inc is an AI company. It designs the world's fastest AI infrastructure for training and inference. The company builds the world's largest semiconductor as well as the AI systems to power, cool, and feed the processors data. It develops software to link these systems together into industry-leading supercomputers that are simple to use even for the most complicated AI work, using familiar ML frameworks like PyTorch. Customers use its supercomputers to train industry-leading models. The company uses these supercomputers to run inference at speeds unobtainable from alternative commercial technologies. It delivers these AI capabilities to its customers on-premise and via the cloud. The company generates the majority of its revenue from the USA.

About GH Guardant Health Inc.

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

Share on Social Networks: